Literature DB >> 32107977

Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes.

Cüneyt Türkeş1, Yeliz Demir2, Şükrü Beydemir3.   

Abstract

Carbonic anhydrases (CAs) are potent dehydration of carbonic acid and catalyst of the reversible hydration of carbon dioxide. Here, CA I and CA II was purified from human erythrocytes using the simple chromatographic method and determined the interactions between some calcium channel blockers and the enzymes. Molecular docking studies were performed these compounds. It was found that calcium channel blockers (nimodipine, nilvadipine, nitrendipine, isradipine, and nifedipine) exhibit potential inhibitor properties for hCA I and hCA II. IC50 values of hCA I were in the range of 9.24-58.00 μM, and Ki constants were in the range of 7.60 ± 2.68-35.92 ± 16.01 μM. IC50 values of hCA II were in the range of 70.00-138.60 μM, and Ki constants were in the range of 48.30 ± 9.81-162.35 ± 20.47 μM. Nimodipine presented the highest docking score and had competitive inhibition, the benzene and pyridine rings were found to enter the cavity for hCA I. Nifedipine and isradipine did not affect hCA II. Among these drugs, nitrendipine was found to be the most potent inhibitor for hCA I and nimodipine for hCA II. These compounds may be useful for CA inhibitors.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  Carbonic anhydrase; calcium channel blockers; enzyme inhibition; enzyme purification; molecular docking

Mesh:

Substances:

Year:  2020        PMID: 32107977     DOI: 10.1080/07391102.2020.1736631

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  5 in total

1.  Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors.

Authors:  Nebih Lolak; Süleyman Akocak; Mustafa Durgun; Hatice Esra Duran; Adem Necip; Cüneyt Türkeş; Mesut Işık; Şükrü Beydemir
Journal:  Mol Divers       Date:  2022-09-22       Impact factor: 3.364

2.  Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors.

Authors:  Yeliz Demir; Feyzi Sinan Tokalı; Erbay Kalay; Cüneyt Türkeş; Pelin Tokalı; Osman Nuri Aslan; Kıvılcım Şendil; Şükrü Beydemir
Journal:  Mol Divers       Date:  2022-09-14       Impact factor: 3.364

Review 3.  Evaluating the Non-conventional Achalasia Treatment Modalities.

Authors:  Francisco Tustumi
Journal:  Front Med (Lausanne)       Date:  2022-06-24

4.  Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif.

Authors:  Özcan Güleç; Cüneyt Türkeş; Mustafa Arslan; Yeliz Demir; Yeşim Yeni; Ahmet Hacımüftüoğlu; Ergün Ereminsoy; Ömer İrfan Küfrevioğlu; Şükrü Beydemir
Journal:  Mol Divers       Date:  2022-04-09       Impact factor: 3.364

5.  Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking.

Authors:  Yaling Hu; Shuang Liu; Wenyuan Liu; Ziyuan Zhang; Yuxiang Liu; Sufen Li; Dalin Sun; Guang Zhang; Jingai Fang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-29       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.